Abingdon Health Limited (ABDX) ORD GBP0.00025

Sell:6.50pBuy:7.00pNo change

Prices delayed by at least 15 minutes
Sell:6.50p
Buy:7.00p
Change:No change
Prices delayed by at least 15 minutes
Sell:6.50p
Buy:7.00p
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Abingdon Health plc is an international lateral flow contract research (CRO) and contract development and manufacturing organization (CDMO). The Company is an international developer, manufacturer and distributor of effective rapid tests. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its CDMO division has the internal capabilities to take lateral flow projects, in areas such as infectious disease and clinical testing, including companion diagnostics, and others. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests. The Abingdon Simply Test’s other selected self-test products, such as the saliva pregnancy test, Salistick, which is sold through international distributors and through other channels in the United Kingdom and Ireland, such as pharmacy chains.

Key people

Thomas Edward Hayes
Chief Financial Officer, Executive Director
Christopher William Hand
Non-Executive Chairman of the Board
Katie Brenner
Non-Executive Independent Director
Mary Geraldine Tavener
Senior Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    ABDX
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB00BLF79J41
  • Market cap
    £13.07m
  • Employees
    85
  • Shares in issue
    193.63m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.